BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma

BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form – ET HealthWorld | Pharma
New Delhi: BDR Pharmaceuticals on Tuesday said it has introduced Enzalutamide oral solution for treatment of prostate cancer, claiming to ...
Read more

US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma

US FDA approvals bounce back in 2023, sparking hopes of a biotech recovery – ET HealthWorld | Pharma
Bengaluru: The US Food and Drug Administration approved nearly 50 per cent more novel drugs in 2023 than in 2022, ...
Read more

AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer – ET HealthWorld | Pharma

AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer – ET HealthWorld | Pharma
Chennai: AstraZeneca India Pharma Ltd officially launched Trastuzumab deruxtecan, therapy tailored for the treatment of adult patients with unresectable or ...
Read more

Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma

Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India – ET HealthWorld | Pharma
Mumbai: Glenmark Pharmaceuticals Ltd has launched a biosimilar of the anti-diabetic drug Liraglutide for the first time in India, The ...
Read more

Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma

Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more

Novartis signs gene therapy deal with Voyager for $100 mln upfront – ET HealthWorld | Pharma

Novartis signs gene therapy deal with Voyager for 0 mln upfront – ET HealthWorld | Pharma
Bangalore: Voyager Therapeutics said on Tuesday Swiss-based drugmaker novartis would pay $100 million upfront as part of a licensing deal ...
Read more

Venus Remedies secures marketing authorisation for docetaxel from Israel, cytarabine from Colombia – ET HealthWorld | Pharma

Venus Remedies secures marketing authorisation for docetaxel from Israel, cytarabine from Colombia – ET HealthWorld | Pharma
Mumbai: Venus Remedies has secured marketing authorization for docetaxel from Israel and cytarabine from Colombia, While docetaxel, an antineoplastic agent, ...
Read more

New weight loss drugs are out of reach for millions of older Americans because Medicare won’t pay – ET HealthWorld | Pharma

New weight loss drugs are out of reach for millions of older Americans because Medicare won’t pay – ET HealthWorld | Pharma
WASHINGTON: New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out ...
Read more

Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma

Cell and gene therapy to have greatest impact on pharmaceutical industry in 2024: GlobalData – ET HealthWorld | Pharma
London: Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on ...
Read more

2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma

2023 has been pivotal for JB Pharma: Nikhil Chopra – ET HealthWorld | Pharma
New Delhi : Nikhil ChopraCEO & Whole Time Director, JB Pharma spoke to ETHealthworld’s Prathiba Raju about how 2023 has ...
Read more
123 Next